Study: Tailored Full-Spectrum Marijuana Extracts Linked to Broad Benefits for Women With Chronic Pain

A new study in Frontiers in Pharmacology finds that full-spectrum marijuana extracts, used with flexible, individualized dosing, were associated with broad improvements for women living with chronic pain syndromes.

The research team from Centro Universitário Unieuro, the State Secretariat of Education of the Federal District and the University of Brasilia analyzed outcomes for 29 Brazilian women treated in real-world clinical practice.

All participants had chronic pain lasting at least three months, with conditions ranging from fibromyalgia and migraine to chronic back and joint pain. Patients received full-spectrum marijuana extracts produced by two patient-led civil societies in Brazil, using CBD-dominant, THC-dominant or mixed formulas. Doses were started low and slowly increased, with CBD-to-THC ratios adjusted over several weeks based on symptom relief and side effects.

Every patient reported some reduction in pain, and most also reported improvements in sleep, fatigue, mood, anxiety, irritability, and daily functioning. Many women said they were better able to work, resume household tasks and participate in family and social life. Overall quality of life was rated as moderately or considerably improved for both patients and their families.

The treatment also coincided with a lower reliance on other medications. Among those already taking pain drugs when they started marijuana extracts, about two-thirds reduced or stopped their analgesics. Half of the patients on medication for anxiety or mood disorders reported cutting back or discontinuing those prescriptions.

Side effects were generally mild to moderate and tended to occur early in treatment. No one stopped using marijuana extracts because of adverse events. The authors note that the open-label, self-reported design and small sample mean controlled trials are still needed, but say the findings support individualized, full-spectrum marijuana therapy as a promising adjunct or primary option for women with chronic pain syndromes.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

More articles from The Marijuana Herald can be found below.

Study: Psilocybin Treatment May Benefit Those With PTSD

Study: Psilocybin Treatment May Benefit Those With PTSD

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

Virginia Lawmaker Files Bill to Legalize Licensed Recreational Cannabis Sales, Increase Possession Limit

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

New Jersey Bill Would Create State-Funded Subsidy to Cut Medical Marijuana Costs for Medicaid Patients

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Survey Finds 59% of Indiana Voters Support Legalizing Recreational Cannabis, 84% Support Medical

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Seven of Eight Remaining NFL Playoff Teams Come From States Where Recreational Marijuana Is Legal

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Washington Bill Would Replace 37% Marijuana Excise Tax With Weight- and Potency-Based Rates

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Legal Cannabis Sales in U.S. Pass $2.3 Billion in December, $27 Billion in 2025

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Gelteq Reports Preclinical Results Showing Oral Gel Boosts CBD Absorption

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Glass House and University of California Berkeley Secure $1.8 Million State Grant to Study Marijuana Crop Yields

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Smart & Safe Florida Raises More Than $52 Million to Support 2026 Marijuana Legalization Initiative

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Study: CBD Shown to Reduce Seizures Across Wide Range of Treatment-Resistant Epilepsies

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Public Marijuana Possession and Consumption Would be Downgraded to Civil Violation Under New Delaware Bill

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Washington, D.C. Medical Marijuana Sales Hit $100.9 Million in 2025 as Patient Count Grows to Nearly 100,000

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Connecticut Sets New Monthly Marijuana Sales Record in December as Prices Hit All-Time Low

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: CBD Shows Potent Antibacterial Activity Against Drug-Resistant Enterococcus Strains

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: Hemp Seed Extracts May Enhance Effectiveness of Antibiotics and Antifungal Medications

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders

Study: CBD Gel Reduced Jaw Muscle Activity in Adults With Temporomandibular Disorders